The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Chai-Adisaksopha C, Crowther M, Isayama T, Lim W. Rivaroxaban with or without aspirin in stable cardiovascular disease. Eikelboom JW, Connolly SJ, Bosch J et al. Apixaban versus warfarin in patients with atrial fibrillation. ![]() Granger CB, Alexander JH, McMurray JJ et al. Oral rivaroxaban for symptomatic venous thromboembolism. Investigators E, Bauersachs R, Berkowitz SD et al. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. ![]() Papers of special note have been highlighted as:
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |